Patent no loss of MatrixView
Tuesday, 19 August, 2008
MatrixView [ASX: MVU] has been awarded a European Patent for its proprietary ABO technology.
The patent has been awarded for the company's proprietary Advanced Binary Optimisation (ABO) technology, which allows MatrixView's healthcare products to provide lossless data streams.
ABO is the backbone of MatrixView's healthcare products - such as its tele-radiology solution - where high-resolution, highly accurate data streams are required.
Its key feature is an ability to provide mathematically lossless data management – the ability to compress large amounts of data without losing any of that data, critical in medical applications.
The company has also applied for patents for ABO from the US.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...
